Proficio Capital Partners LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 37,687 shares of the company's stock, valued at approximately $5,636,000.
Other large investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. purchased a new stake in shares of DaVita in the 4th quarter worth $41,000. Quarry LP purchased a new stake in shares of DaVita in the 3rd quarter worth $60,000. Venturi Wealth Management LLC raised its position in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares in the last quarter. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. raised its position in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after acquiring an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.
DaVita Price Performance
DVA stock traded down $0.77 during mid-day trading on Thursday, reaching $149.06. 859,141 shares of the company's stock were exchanged, compared to its average volume of 781,845. The company has a market cap of $11.92 billion, a price-to-earnings ratio of 13.88, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The stock's 50 day moving average is $158.73 and its 200 day moving average is $157.55. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60.
DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st. Barclays upped their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, DaVita currently has a consensus rating of "Hold" and an average target price of $166.33.
Check Out Our Latest Stock Analysis on DaVita
About DaVita
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories

Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.